This new piece of data obtained from the analyses of maternal blood is consistent with previous data obtained by our group that showed how MFSD2A level in placenta of these GDM subjects was reduced at delivery, affecting, in turn, DHA materno-fetal transfer (23). Here, MFSD2A is linked to gestational diabetes.